FDA Recognition of IQOS Reignites Debate Over Tobacco Harm Reduction Policies

The recent re-issuance of Modified Risk Tobacco Product (MRTP) authorizations for a number of IQOS heated tobacco devices is yet another milestone in the international tobacco harm reduction dialogue by the U.S. Food and Drug Administration (FDA). The FDA stated that Philip Morris International (PMI) can continue marketing IQOS, highlighting that switching completely from cigarettes […]